PhaseV

Unlearn focuses on artificial intelligence and digital twin technology within the clinical research sector. The company provides a platform that creates digital twins of clinical trial participants to predict outcomes and streamline the trial process. Unlearn's solutions aim to improve clinical trials by offering insights and decision support. It was founded in 2017 and is based in San Francisco, California.

Nova In Silico specializes in the development of a clinical trial simulation platform within the biotechnology and pharmaceutical industry. Their main offering, jinkō, is a tool that streamlines clinical trials by using disease models and digital patients to predict clinical outcomes and optimize trial design. The platform is primarily utilized by biotech and pharma companies, academic research centers, and not-for-profit organizations to accelerate and de-risk the drug development process. It was founded in 2010 and is based in Lyon, France.

Terray Therapeutics is a biotechnology company that focuses on the discovery and development of small molecule therapeutics. The company offers a platform that integrates ultra-high throughput experimentation with generative AI to improve drug discovery processes. Terray Therapeutics primarily serves the pharmaceutical and biotechnology sectors, using its platform to work with companies on various therapeutic targets. It was founded in 2018 and is based in Monrovia, California.

Galixir is a biotech company engaged in the development, application, and promotion of artificial intelligence technology to develop new drugs. The company aims to support the research and development of both generic drugs and new drugs, develop artificial intelligence technology, optimize chemical synthesis pathways, and reduce drug manufacturing time and costs. The company was founded in 2019 and is based in Haidian, Beijing.

Acellera is involved in drug discovery by integrating AI and quantum chemistry in the pharmaceutical and biotechnology sectors. The company's offerings include a platform for small-molecule discovery and potency optimization that utilizes quantum chemistry and AI/ML for lead candidate identification. The company serves the pharmaceutical and biotech industries. It was founded in 2006 and is based in Barcelona, Spain.

DEARGEN is a pharmatech company that focuses on the drug discovery and development sector. The company offers a platform that integrates deep learning technology for genome data analysis, biomarker prediction, molecule selection, and lead optimization. The platform is used for discovering disease targets and developing small molecules for new drug design. It was founded in 2016 and is based in Daejeon, South Korea.